Investigating new drug discovery methods for cancer treatment
Core-based scientist specializing in high throughput screening for early drug discovery, target identification and systems biology analysis of cancer
This study is looking for new drugs to help treat cancer by testing lots of different small molecules to see which ones can effectively target cancer cells, with the hope of finding better treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10692883 on NIH RePORTER |
What this research studies
This research focuses on developing high throughput screening techniques to identify potential drug candidates for cancer treatment. By utilizing advanced assay development and data analysis methods, the project aims to discover small-molecule probes that can target cancer cells effectively. Patients may benefit from innovative therapies that arise from this research, as it seeks to enhance the understanding of cancer biology and improve treatment options. The work is conducted at the University of Iowa's High Throughput Screening Facility, which collaborates with the Holden Comprehensive Cancer Center.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from novel treatment options.
Not a fit: Patients with non-malignant conditions or those who are not currently undergoing cancer treatment may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective cancer therapies.
How similar studies have performed: Previous research in high throughput screening has shown success in identifying effective cancer treatments, indicating a promising approach.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Wu, Meng — Ohio State University
- Study coordinator: Wu, Meng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.